Page last updated: 2024-08-21

adamantane and AIDS-Related Opportunistic Infections

adamantane has been researched along with AIDS-Related Opportunistic Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rohde, GG1
Zhang, Y1

Reviews

1 review(s) available for adamantane and AIDS-Related Opportunistic Infections

ArticleYear
Advances in the treatment of tuberculosis.
    Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:5

    Topics: Adamantane; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Investigational; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin; Treatment Refusal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2007

Other Studies

1 other study(ies) available for adamantane and AIDS-Related Opportunistic Infections

ArticleYear
[Influenza : clinical symptoms, diagnostics and therapy].
    Der Internist, 2011, Volume: 52, Issue:9

    Topics: Adamantane; Adult; Age Factors; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Female; Germany; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Neuraminidase; Pandemics; Pneumonia, Viral; Population Surveillance; Pregnancy; Rimantadine; Survival Rate

2011